Safety, metabolic and psychological outcomes of Medtronic MiniMed 780G™ in children, adolescents and young adults: a systematic review
S Passanisi, F Lombardo, C Mameli, B Bombaci… - Diabetes Therapy, 2024 - Springer
Abstract The MiniMed™ 780G is a second-generation automated insulin delivery system
that implements a modified proportional–integral–derivative algorithm with some features of …
that implements a modified proportional–integral–derivative algorithm with some features of …
7. Diabetes Technology: Standards of Care in Diabetes—2024
Diabetes Care, 2024 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …
ADA's current clinical practice recommendations and is intended to provide the components …
Real-world evidence of automated insulin delivery system use
EG Considine, JL Sherr - Diabetes Technology & Therapeutics, 2024 - liebertpub.com
Objective: Pivotal trials of automated insulin delivery (AID) closed-loop systems have
demonstrated a consistent picture of glycemic benefit, supporting approval of multiple …
demonstrated a consistent picture of glycemic benefit, supporting approval of multiple …
7. Diabetes Technology: Standards of Care in Diabetes—2024.
NA ElSayed, G Aleppo, RR Bannuru… - Diabetes …, 2024 - search.ebscohost.com
Abstract The American Diabetes Association (ADA)" Standards of Care in Diabetes"
includes the ADA's current clinical practice recommendations and is intended to provide the …
includes the ADA's current clinical practice recommendations and is intended to provide the …
Aiming for the best glycemic control beyond time in range: time in tight range as a new continuous glucose monitoring metric in children and adolescents with type 1 …
S Passanisi, C Piona, G Salzano… - Diabetes Technology …, 2024 - liebertpub.com
Introduction: To evaluate time in tight range (TITR) 70–140 mg/dL (3.9–7.8 mmol/L), its
correlation with standard continuous glucose monitoring (CGM) metrics and the clinical …
correlation with standard continuous glucose monitoring (CGM) metrics and the clinical …
Celebrating the data from 100,000 real-world users of the MiniMed™ 780G system in Europe, Middle East, and Africa collected over 3 years: from data to clinical …
P Choudhary, A Arrieta, T van den Heuvel… - Diabetes Technology …, 2024 - liebertpub.com
Introduction: The present report celebrates the benchmarking of 100,000 MiniMed™ 780G
system users in Europe, Middle East, and Africa (EMEA) and summarizes the major insights …
system users in Europe, Middle East, and Africa (EMEA) and summarizes the major insights …
Twelve‐month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed‐loop therapy outcomes versus …
SN Edd, J Castañeda, P Choudhary… - Diabetes, Obesity …, 2023 - Wiley Online Library
Aims To reassess the 6‐month efficacy and to assess the 12‐month sustained efficacy of the
MiniMed™ 780G advanced hybrid closed‐loop automated insulin delivery (AID) system …
MiniMed™ 780G advanced hybrid closed‐loop automated insulin delivery (AID) system …
Results from a virtual clinic for the follow-up of patients using the advanced hybrid closed-loop system
AM Gómez Medina, DC Henao Carrillo… - Journal of Diabetes …, 2023 - journals.sagepub.com
Background: Evidence regarding the implementation of medium-term strategies in advanced
hybrid closed-loop (AHCL) system users is limited. Therefore, this study aimed to describe …
hybrid closed-loop (AHCL) system users is limited. Therefore, this study aimed to describe …
A Peek Under the Hood: Explaining the MiniMed™ 780G Algorithm with Meal Detection Technology
The MiniMed™ 780G system (780G) received Conformité Européenne mark in June 2020
and was, recently, approved by the US Food and Drug Administration (April 2023). Clinical …
and was, recently, approved by the US Food and Drug Administration (April 2023). Clinical …
Early Real-World Performance of the MiniMed™ 780G Advanced Hybrid Closed-Loop System and Recommended Settings Use in the United States
JR Thrasher, A Arrieta, F Niu, KR Cameron… - Diabetes Technology …, 2024 - liebertpub.com
Background: The MiniMed™ 780G system (MM780G) with Guardian™ 4 sensor includes a
100 mg/dL glucose target (GT) and automated insulin corrections up to every 5 min and was …
100 mg/dL glucose target (GT) and automated insulin corrections up to every 5 min and was …